# Eberhard Standl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eberhard-standl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,428 |
| Field | Diabetes Treatment and Management |
| h-index | 57 |
| i10-index | 178 |
| Last Known Institution | Helmholtz Zentrum München |
| OpenAlex ID | https://openalex.org/A5090174827 |
| ORCID iD | https://orcid.org/0000-0002-8667-633X |
| Works | 373 |

## Researcher papers

- [Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial](https://scholariq.org/papers/secondary-prevention-of-macrovascular-events-in-patients-with-type-2-diabetes-in/)
- [Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-sitagliptin-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effects-of-acarbose-on-cardiovascular-and-diabetes-outcomes-in-patients-with/)
- [Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials](https://scholariq.org/papers/benefits-and-harms-of-drug-treatment-for-type-2-diabetes-systematic-review-and/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)

## Researcher university

- [Helmholtz Munich](https://scholariq.org/institutions/helmholtz-munich/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.